Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Post by frankmanon Jan 07, 2020 10:02am
274 Views
Post# 30525516

Revenues have increased 223% (on the right path)

Revenues have increased 223% (on the right path)Increase in revenue by 223% is primarily due to an increase in sales of dried cannabis to provincial liquor and cannabis boards as the Company continues to increase sales volume to the Ontario Cannabis Store, the online retail brand of the Ontario Cannabis Retail Corporation since February 1, 2019, compared to the same period in the prior year when legalization came into effect as of October 17, 2018. The Company anticipates further growth in cannabis revenue upon completion and licensing of Acreage Pharms’ Phase III cultivation facility and the sale of oil products.


Revenues  October 31, 2019   $3,386,646

Revenues   October 31, 2018   $1,048,864
<< Previous
Bullboard Posts
Next >>